Tuesday, June 5, 2018

Osteoporosis drug prevents spread of basal-like breast cancer in mice

›
In continuation of my update on zoledronic acid  Researchers in China have discovered that an enzyme called UGT8 drives the progressio...
Saturday, June 2, 2018

Baldness treatment using a medication for osteoporosis

›
According to study leader Nathan Hawkshaw, of the University of Manchester in England, this new drug has never been considered in the trea...
Friday, June 1, 2018

ONC201 disrupts mitochondrial function and kills breast cancer cells, reveals study

›
TRAIL, a member of the TNF family of ligands, causes caspase-dependent apoptosis through activation of its receptors, death receptor 4 a...
Thursday, May 31, 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

›
  In continuation of my update on  dabrafenib &  trametinib       dabrafenib                    trametinib The U.S. Food an...
Wednesday, May 30, 2018

New chemical trap catches trace glycoproteins, shows promise for targeted cancer treatments

›
Cancer drops sparse chemical hints of its presence early on, but unfortunately, many of them are in a class of biochemicals that could not...
Tuesday, May 29, 2018

Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients with COPD

›
In continuation of my update on  fluticasone furoate , umeclidinium and vilantero l GlaxoSmithKline plc   and Innoviva, Inc.    annou...
1 comment:
Saturday, May 26, 2018

FDA Advisory Committee Votes in Favor of Lucemyra (lofexidine) for the Mitigation of Opioid Withdrawal Symptoms

›
US WorldMeds,  announced that the US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee voted 11 to 1...
Friday, May 25, 2018

Paratek’s New Drug Applications for Oral and Intravenous Omadacycline Accepted for Priority Review by FDA

›
P aratek Pharmaceuticals, Inc.   announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Applications (NDAs) ...
Thursday, May 24, 2018

Rubraca (rucaparib) Approved in the U.S. as Maintenance Treatment of Recurrent Ovarian Cancer

›
In continuation of my update on  Rucaparib Clovis Oncology, Inc. announced that the U.S. Food and Drug Administration (FDA) has ap...
Wednesday, May 23, 2018

Mylan Introduces Symfi (efavirenz, lamivudine and tenofovir disoproxil fumarate) Triple Combo Once-Daily HIV Treatment in the U.S.

›
               Tenofovir disoproxil fumarate                               Lamivudine                    Efavirenz             In ...
Tuesday, May 22, 2018

Pacira Announces FDA Approval of Exparel as a Nerve Block to Produce Regional Analgesia

›
Pacira Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental new drug appl...
Friday, May 18, 2018

UCB Announces Briviact (brivaracetam) Now Approved by FDA to Treat Partial-Onset (Focal) Seizures in Pediatric Epilepsy Patients

›
 In continuation of my update on  brivaracetam UCB announced today that the U.S. Food and Drug Administration (FDA) has approved a...

Novartis Receives FDA Approval of Tafinlar + Mekinist for Adjuvant Treatment of BRAF V600-Mutant Melanoma

›
Novartis announced that the US Food and Drug Administration (FDA) has approved  Tafinlar ® ( dabrafenib ) in combination with  Mekinist ...
Thursday, May 17, 2018

FDA Expands Approval of Gilenya (fingolimod) to Treat Multiple Sclerosis in Pediatric Patients

›
In continuation of my update on  fingolimod The U.S. Food and Drug Administration today approved  Gilenya  ( fingolimod ) to...